Mesenchymal stem cells (MSC) immunomodulation in Type I Diabetes Mellitus
JooHyun Julie Oh Type 1 diabetes mellitus (T1DM) is caused by autoimmune destruction of pancreatic islet β cells, which results in loss of insulin production and secretion1. Approximately 1.25 million Americans have T1DM in the United States and incidence is increasing at a rate of 3-4% every year, notably among…